| Brim-Dor™ PF (U.S.N.L.M.) | |
|---|---|
| Dosing | b.i.d. |
| Chem Specs | brimonidine 0.15%, dorzolamide 2.0% |
| Quantities | 10ml, |
| Cost | 108.00 |
| Class |
brimonidine: Relatively selective alpha-2 agonist. dorzolamide: Carbonic anhydrase inhibitor |
| Usage | Preservative-free, single container preparation can reduce surface toxicity and enhance compliance. Requires refrigeration. |
| Contraindications |
brimonidine neonates and infants (under the age of 2 years)
dorzolamide Sulfonamide hypersensitivity. |
| Pediatric use | Safety and effectiveness in pediatric patients have not been established. |
| Pregnancy | Category C. Animal teratogenicity at 37 times the normal human ophthalmic dose. |
| Bottle with one way valve requires Refrigeration. Individual drugs are FDA approved but the combination is not. |